Cargando…

A specific JMJD6 inhibitor potently suppresses multiple types of cancers both in vitro and in vivo

Jumonji C-domain-containing protein 6 (JMJD6), an iron (Fe(2+)) and α-ketoglutarate (α-KG)-dependent oxygenase, is expressed at high levels, correlated with poor prognosis, and considered as a therapeutic target in multiple cancer types. However, specific JMJD6 inhibitors that are potent in suppress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Rong-quan, Ran, Ting, Huang, Qi-xuan, Hu, Guo-sheng, Fan, Da-meng, Yi, Jia, Liu, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2022
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407455/ https://www.ncbi.nlm.nih.gov/pubmed/35969736 http://dx.doi.org/10.1073/pnas.2200753119

Ejemplares similares

Picropodophyllin (PPP) is a potent rhabdomyosarcoma growth inhibitor both in vitro and in vivo
por: Tarnowski, Maciej, et al.
Publicado: (2017)

Histone Demethylase JMJD3 Mediated Doxorubicin-Induced Cardiomyopathy by Suppressing SESN2 Expression
por: Wang, Panxia, et al.
Publicado: (2020)

EGFR‐targeted CAR‐T cells are potent and specific in suppressing triple‐negative breast cancer both in vitro and in vivo
por: Xia, Lin, et al.
Publicado: (2020)

The histone demethylase JMJD2B regulates endothelial-to-mesenchymal transition
por: Glaser, Simone F., et al.
Publicado: (2020)

Widespread hydroxylation of unstructured lysine-rich protein domains by JMJD6
por: Cockman, Matthew E., et al.
Publicado: (2022)

Phosphodiesterase 3/4 Inhibitor Zardaverine Exhibits Potent and Selective Antitumor Activity against Hepatocellular Carcinoma Both In Vitro and In Vivo Independently of Phosphodiesterase Inhibition
por: Sun, Liping, et al.
Publicado: (2014)

JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner
por: Yi, Jia, et al.
Publicado: (2017)

Both EZH2 and JMJD6 regulate cell cycle genes in breast cancer
por: Biswas, Antara, et al.
Publicado: (2020)

Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple Myeloma
por: Drew, Allison E., et al.
Publicado: (2017)

The Novel Protease Activities of JMJD5–JMJD6–JMJD7 and Arginine Methylation Activities of Arginine Methyltransferases Are Likely Coupled
por: Liu, Haolin, et al.
Publicado: (2022)

Epigenetic Control of Autophagy Related Genes Transcription in Pulpitis via JMJD3
por: Yin, Bei, et al.
Publicado: (2021)

Specific Recognition of Arginine Methylated Histone Tails by JMJD5 and JMJD7
por: Liu, Haolin, et al.
Publicado: (2018)

Effects of Simvastatin on the Metabolism of Vonoprazan in Rats Both in vitro and in vivo
por: Hong, Yun, et al.
Publicado: (2022)

Development of highly potent melanogenesis inhibitor by in vitro, in vivo and computational studies
por: Abbas, Qamar, et al.
Publicado: (2017)

Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo
por: Tanimoto, Atsuo, et al.
Publicado: (2014)

Protamine Sulfate Is a Potent Inhibitor of Human Papillomavirus Infection In Vitro and In Vivo
por: Young, Jesse M., et al.
Publicado: (2022)

Macrocyclic Peptidomimetic Plasmepsin X Inhibitors with Potent In Vitro and In Vivo Antimalarial Activity
por: Kovada, Vadims, et al.
Publicado: (2023)

Combination of Melatonin and Zoledronic Acid Suppressed the Giant Cell Tumor of Bone in vitro and in vivo
por: Wang, Xudong, et al.
Publicado: (2021)

Moscatilin Suppresses the Breast Cancer Both In Vitro and In Vivo by Inhibiting HDAC3
por: Su, Wenjie, et al.
Publicado: (2021)

JMJD1C Regulates Megakaryopoiesis in In Vitro Models through the Actin Network
por: Wang, Jialing, et al.
Publicado: (2022)

The Marine-Derived Oligosaccharide Sulfate (MdOS), a Novel Multiple Tyrosine Kinase Inhibitor, Combats Tumor Angiogenesis both In Vitro and In Vivo
por: Ma, Jingui, et al.
Publicado: (2008)

In Vitro and In Vivo Metabolism and Inhibitory Activities of Vasicine, a Potent Acetylcholinesterase and Butyrylcholinesterase Inhibitor
por: Liu, Wei, et al.
Publicado: (2015)

JMJD1C Exhibits Multiple Functions in Epigenetic Regulation during Spermatogenesis
por: Nakajima, Ryusuke, et al.
Publicado: (2016)

Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes
por: Watters, Kyle E., et al.
Publicado: (2020)

JMJD3 suppresses tumor progression in oral tongue squamous cell carcinoma patients receiving surgical resection
por: Chen, Yen-Hao, et al.
Publicado: (2022)

Bepridil is potent against SARS-CoV-2 in vitro
por: Vatansever, Erol C., et al.
Publicado: (2021)

Synergistic action by multi-targeting compounds produces a potent compound combination for human NSCLC both in vitro and in vivo
por: Zhang, C, et al.
Publicado: (2014)

Exosomes-Coated miR-34a Displays Potent Antitumor Activity in Pancreatic Cancer Both in vitro and in vivo
por: Zuo, Ling, et al.
Publicado: (2020)

Role of JMJD6 in Breast Tumourigenesis
por: Poulard, Coralie, et al.
Publicado: (2015)

JMJD3 in the regulation of human diseases
por: Zhang, Xiangxian, et al.
Publicado: (2019)

The Functions of the Demethylase JMJD3 in Cancer
por: Sanchez, Anna, et al.
Publicado: (2021)

JMJD family proteins in cancer and inflammation
por: Manni, Wang, et al.
Publicado: (2022)

Impact of JMJD6 on intrahepatic cholangiocarcinoma
por: Kosai-Fujimoto, Yukiko, et al.
Publicado: (2022)

Discovering the Potent Inhibitors Against Babesia bovis in vitro and Babesia microti in vivo by Repurposing the Natural Product Compounds
por: Li, Yongchang, et al.
Publicado: (2021)

JMJD6 Dysfunction Due to Iron Deficiency in Preeclampsia Disrupts Fibronectin Homeostasis Resulting in Diminished Trophoblast Migration
por: Alahari, Sruthi, et al.
Publicado: (2021)

Global gene expression profiling of JMJD6- and JMJD4-depleted mouse NIH3T3 fibroblasts
por: Hu, Yu-Jie, et al.
Publicado: (2016)

Potent Antimalarial Activity of Acriflavine In Vitro and In Vivo
por: Dana, Srikanta, et al.
Publicado: (2014)

α-Conotoxins Enhance both the In Vivo Suppression of Ehrlich carcinoma Growth and In Vitro Reduction in Cell Viability Elicited by Cyclooxygenase and Lipoxygenase Inhibitors
por: Osipov, Alexey V., et al.
Publicado: (2020)

FDA-Approved Inhibitors of RTK/Raf Signaling Potently Impair Multiple Steps of In Vitro and Ex Vivo Influenza A Virus Infections
por: Meineke, Robert, et al.
Publicado: (2022)

Effects of bergapten on the pharmacokinetics of macitentan in rats both in vitro and in vivo
por: Xu, Jia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ljmc9blnv213b583ocb54r976e